United Therapeutics Corporation v. Commissioner of Internal Revenue
Case Number:
23-1718
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
June 24, 2024
4th Circ. Affirms Nix Of $1.2M R&D Credit For Biotech Co.
A biotechnology company that claimed tax credits for increasing its scientific research was correctly denied about $1.2 million of its request, the Fourth Circuit ruled Monday in upholding a U.S. Tax Court decision that found the company was wrongly counting research expenses twice.
-
January 25, 2024
4th Circ. Skeptical Of Biotech Co.'s Tax Credit Claim
The Fourth Circuit questioned a biotechnology company's claim that it was wrongly deprived of tax credits for drug research, asking Thursday why the company rejected the U.S. Tax Court's ruling that it should have included clinical expenses in its calculation.
-
January 22, 2024
4th Circ. Preview: Timberland's TM Bid Kicks Off 2024
The Fourth Circuit will kick off 2024 by probing Timberland's bid to trademark its footwear and pondering an embattled insurance mogul's attempt to escape a $524 million judgment.
-
November 06, 2023
Biotech Co. Merits Extra $1.2M Research Credit, 4th Circ. Told
A biotechnology company was wrongly stripped of tax credits for increasing its scientific research, it told the Fourth Circuit on Monday, saying it correctly excluded $26.6 million in clinical testing expenses from its baseline calculation, which should have entitled it to claim another $1.2 million.
-
October 17, 2023
Biotech Co. Inflated R&D Claim By $1.2M, 4th Circ. Told
A biotechnology company that claimed tax credits for increasing its scientific research improperly excluded $26.6 million in clinical testing expenses from its baseline calculation, juicing its claim by $1.2 million, the Internal Revenue Service told the Fourth Circuit.